Ning Liu

Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis

Ning Liu, Zhen Wang, Weidong Gan et al. · PLoS ONE · 2016 · 40 citations · Full text

Surgical Oncology, Renal Pathology, Pathology +16

Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype

Ning Liu, Daoguang Huang, Xiangming Cheng et al. · Urologic Oncology Seminars and Original Investigations · 2017 · 39 citations

Urology, Surgical Oncology, Genitourinary Cancer +8

Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients

Sezim Agizamhan, Feng Qu, Ning Liu et al. · BMC Urology · 2018 · 19 citations · Full text

PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue

Lei Xiong, Xiancheng Chen, Ning Liu et al. · PLoS ONE · 2017 · 14 citations · Full text

Tumor Biology, Urology, Tumoral Pathology +13

Does the Fuhrman or World Health Organization/International Society of Urological Pathology Grading System Apply to the Xp11.2 Translocation Renal Cell Carcinoma?

Ning Liu, Weidong Gan, Feng Qu et al. · American Journal Of Pathology · 2018 · 13 citations · Full text